The pharmaceutical industry has survived every Senate hearing on drug pricing. It has managed every press release, co-opted every regulatory process, and spent $450 million making sure its lobbying operation reaches every member of Congress before any reform bill does. There is one accountability mechanism it has no infrastructure for. The ballot box doesn't negotiate, doesn't accept contributions, and doesn't revolve. It counts. November 2026. Use it.